Predictive Factor to Castrate-Resistant Prostate Cancer (CRPC) After Primary Androgen Deprivation Therapy (ADT): Single Center Experience in Indonesia

International Journal of Innovative Technology and Exploring Engineering - India
doi 10.35940/ijitee.c1072.0193s20
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Blue Eyes Intelligence Engineering and Sciences Engineering and Sciences Publication - BEIESP

Related search

Androgen Deprivation Therapy for Prostate Cancer

2017English

Current Options and Future Directions in Castrate Resistant Prostate (CRPC)

2011English

Genome-Wide Alterations in Gene Expression of Prostate Cancer (PC) Cells Surviving Neoadjuvant Androgen Deprivation Therapy (ADT).

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2017English

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men With Prostate Cancer

Journal of Cancer
Oncology
2014English

Does Use of Androgen Deprivation Therapy (ADT) in Men With Prostate Cancer Increase the Risk of Sarcopenia?

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Crosstalk Between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2008English

Adaptive Phenotype Drives Resistance to Androgen Deprivation Therapy in Prostate Cancer

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Castration-Resistant Prostate Cancer: A Strategy to Enhance Response to Androgen Deprivation

Asian Journal of Andrology
MedicineUrology
2013English

Androgen Deprivation Therapy in Nonmetastatic Prostate Cancer Patients: Indications, Treatment Effects, and New Predictive Biomarkers

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy